Metabolic and cardiovascular side effects of the beta 2-adrenoceptor agonists salbutamol and rimiterol.
Phillips PJ, Vedig AE, Jones PL, Chapman MG, Collins M, Edwards JB, Smeaton TC, Duncan BM.
Phillips PJ, et al.
Br J Clin Pharmacol. 1980 May;9(5):483-91. doi: 10.1111/j.1365-2125.1980.tb05844.x.
Br J Clin Pharmacol. 1980.
PMID: 6104976
Free PMC article.
Clinical Trial.
The metabolic and cardiovascular side-effects of intravenous infusions of therapeutic doses of beta 2-adrenoceptor agonists salbutamol and rimiterol have been determined in four healthy male subjects. There were dose-related increases in plasma glucose, renin activity, ser …
The metabolic and cardiovascular side-effects of intravenous infusions of therapeutic doses of beta 2-adrenoceptor agonists salbutamol and …